Belupo d.d., Koprivnica, Croatia   Report issue

For profit Phase 4
Founded: Koprivnica Croatia (Hrvatska) (1970)
Status: No NME R&D (1970)

Organization Overview

First Clinical Trial
2010
NCT03086070
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Belupo | Belupo d.o.o., Koprivnica, Croatia

Active Ingredients

Drugs in Phase 4 Trials (2)

omeprazole (prilosec) (1 trial)

silymarin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatty Liver (Phase 4)

Gastroesophageal Reflux (Phase 4)

Laryngopharyngeal Reflux (Phase 4)

Liver Diseases (Phase 4)

Non-alcoholic Fatty Liver Disease (Phase 4)

Sinusitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2